Epidemiological Characteristics of Tuberculosis Among Interprovincial Migrants — China, 2019–2023
China CDC Weekly · 2025 · 7 (33) · 1079-1086
DOI: 10.46234/ccdcw2025.180 ↗Kurz gefasst
Fachartikel in der Zeitschrift China CDC Weekly, 2025. Verfasst von Da Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
- Chinese Field Epidemiology Training Program, Chinese Centre for Disease Control and Prevention, Beijing, China.
- National Center for Tuberculosis Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China.
- Daxing Center for Disease Control and Prevention, Beijing, China.
- Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning City, Guangxi Zhuang Autonomous Region, China.
Zitieren
APA
Xu, D., Li, X., Tian, F., Cui, Z., & Chen, W. (2025). Epidemiological Characteristics of Tuberculosis Among Interprovincial Migrants — China, 2019–2023. China CDC Weekly, 7(33), 1079-1086. https://doi.org/10.46234/ccdcw2025.180
Vancouver
Xu D, Li X, Tian F, Cui Z, Chen W. Epidemiological Characteristics of Tuberculosis Among Interprovincial Migrants — China, 2019–2023. China CDC Weekly. 2025;7(33):1079-1086. doi:10.46234/ccdcw2025.180
BibTeX
@article{Xu2025,
author = {Xu, Da and Li, Xue and Tian, Feifei and Cui, Zhezhe and Chen, Wei},
title = {Epidemiological Characteristics of Tuberculosis Among Interprovincial Migrants — China, 2019–2023},
journal = {China CDC Weekly},
year = {2025},
volume = {7},
number = {33},
pages = {1079--1086},
doi = {10.46234/ccdcw2025.180}
}
EUVIMED